| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |